Skip to search.
 TSX Down 1.79% TSX Ventures Up 0.02%

Gilead Sciences Inc. (GILD)

-NasdaqGS
85.26 Up 0.12(0.14%) 4:00PM EST
|After Hours : 85.35 Up 0.09 (0.11%) 4:16PM EST - Nasdaq Real Time Price
Prev Close:85.14
Open:84.00
Bid:85.31 x 400
Ask:85.40 x 300
1y Target Est:118.63
Beta:1.40682
Earnings Date:Apr 28 - May 2 (Est.)
Day's Range:83.86 - 86.65
52wk Range:81.89 - 123.37
Volume:18,832,863
Avg Vol (3m):10,533,700
Market Cap:121.24B
P/E (ttm):7.16
EPS (ttm):11.91
Div & Yield:1.72 (2.02%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDUp 0.14%121.24B
GSKDown 3.16%95.52B
PFEDown 1.62%176.32B

Key Statistics

Forward P/E (1 yr):6.79
P/S (ttm):3.71
Ex-Dividend Date:14-Dec-15

Analysts

Annual EPS Est (Dec-16) :12.25
Quarterly EPS Est (Mar-16) :3.08
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):0.72

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback